219 related articles for article (PubMed ID: 33941118)
1. Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.
Wang C; Hu K; Deng L; He W; Fang F; Tamimi RM; Lu D
BMC Cancer; 2021 May; 21(1):491. PubMed ID: 33941118
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy.
Wang C; Hu K; Luo C; Deng L; Fall K; Tamimi RM; Valdimarsdóttir UA; Fang F; Lu D
Br J Cancer; 2021 Nov; 125(10):1450-1458. PubMed ID: 34580431
[TBL] [Abstract][Full Text] [Related]
3. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
Guo X; Liu M; Hou H; Liu S; Zhang X; Zhang Y; Wu P; Pang C; Wang J
Int J Clin Oncol; 2019 Aug; 24(8):957-965. PubMed ID: 30903422
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
Donin N; Filson C; Drakaki A; Tan HJ; Castillo A; Kwan L; Litwin M; Chamie K
Cancer; 2016 Oct; 122(19):3075-86. PubMed ID: 27377470
[TBL] [Abstract][Full Text] [Related]
5. Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.
Mery CM; George S; Bertagnolli MM; Raut CP
Cancer; 2009 Sep; 115(18):4055-63. PubMed ID: 19526590
[TBL] [Abstract][Full Text] [Related]
6. Mortality of lung cancer as a second primary malignancy: A population-based cohort study.
Deng L; Harðardottír H; Song H; Xiao Z; Jiang C; Wang Q; Valdimarsdóttir U; Cheng H; Loo BW; Lu D
Cancer Med; 2019 Jun; 8(6):3269-3277. PubMed ID: 30993899
[TBL] [Abstract][Full Text] [Related]
7. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
8. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
11. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
12. Short-term mortality risks among patients with non-metastatic bladder cancer.
Zhai M; Tang C; Li M; Chen X; Jin Y; Ying X; Tang Z; Wang X; Wu Y; Sun C; Chen K; Guo X
BMC Cancer; 2020 Nov; 20(1):1148. PubMed ID: 33238972
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.
Lv F; Cheng M; Jiang L; Zhao X
Sci Rep; 2021 Jul; 11(1):14790. PubMed ID: 34285322
[TBL] [Abstract][Full Text] [Related]
14. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
15. Mortality after contralateral breast cancer in Denmark.
Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
[TBL] [Abstract][Full Text] [Related]
16. The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction.
Wang Z; Zhou Y; Guan C; Ding Y; Tao S; Huang X; Chen L; Zhang F; Zhang R
Medicine (Baltimore); 2020 Sep; 99(38):e22191. PubMed ID: 32957347
[TBL] [Abstract][Full Text] [Related]
17. Cause-specific mortality among patients with different molecular subtypes of T1-2N0M0 breast cancer: A population-based study.
Wang D; Yi L; Zhang L; Wang Z
Medicine (Baltimore); 2021 Oct; 100(43):e27605. PubMed ID: 34713838
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
[TBL] [Abstract][Full Text] [Related]
19. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
Wei JL; Jiang YZ; Shao ZM
Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
